U.S. Water Utilities Stock News

NasdaqGS:VIR
NasdaqGS:VIRBiotechs

A Look At Vir Biotechnology (VIR) Valuation After New SOLSTICE Trial Data And Pipeline Updates

Why Vir Biotechnology’s latest clinical data matters for investors Vir Biotechnology (VIR) recently reported new positive data from its SOLSTICE Phase 2 trial in chronic hepatitis delta, highlighting stronger and more sustained hepatitis delta virus RNA suppression for its tobevibart and elebsiran combination through 96 weeks. The company also used the 44th Annual J.P. Morgan Healthcare Conference to outline broader clinical plans, including the ECLIPSE Phase 3 program in hepatitis delta and...
NYSE:WWW
NYSE:WWWLuxury

Assessing Wolverine World Wide (WWW) Valuation After Recent Share Price Swings

Event-driven snapshot of Wolverine World Wide Wolverine World Wide (WWW) has drawn investor attention after recent share price swings, with the stock up around 10% over the past month but showing a decline across the past 3 months. See our latest analysis for Wolverine World Wide. At a share price of $19.28, Wolverine World Wide’s recent 10.05% 1 month share price return contrasts with its 26.24% 3 month share price decline and a 12.41% 1 year total shareholder return loss, suggesting...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Is Regeneron Pharmaceuticals (REGN) Still Attractive After Recent Share Price Weakness?

If you are wondering whether Regeneron Pharmaceuticals at around US$755 per share still offers value, you are not alone. The answer depends on how you look at its fundamentals versus its current price. Over the last week the stock returned 1.8%, while the 30 day return was a 3.8% decline and the year to date return sits at a 2.7% decline, with a 9.4% return over the past year and 50.1% over five years. Investors have been watching Regeneron closely as fresh company specific news and sector...
NasdaqGS:LYTS
NasdaqGS:LYTSElectrical

LSI Industries (LYTS) Margin Dip To 4.3% Tests Bullish Earnings Growth Narrative

LSI Industries (LYTS) has just posted Q2 2026 results with revenue of US$147.0 million and basic EPS of US$0.20, alongside trailing twelve month revenue of US$591.8 million and EPS of US$0.84 that frame the latest quarter against a fuller year of operations. The company has seen quarterly revenue move from US$147.7 million and EPS of US$0.19 in Q2 2025 to US$147.0 million and EPS of US$0.20 in Q2 2026, with net income shifting from US$5.6 million to US$6.3 million over the same period, while...
NasdaqGS:DXPE
NasdaqGS:DXPETrade Distributors

Is It Time To Reassess DXP Enterprises (DXPE) After Recent Share Price Strength

If you are wondering whether DXP Enterprises' current share price lines up with its underlying value, you are not alone. This article walks through what the numbers actually say. With the stock at US$132.09 and recent returns of 9.4% over 7 days, 14.4% over 30 days, 22.6% year to date and 23.4% over 1 year, many investors are reassessing both the growth potential and the level of risk they are comfortable with. DXP Enterprises has also been in the news for its role as a distributor and...
NasdaqGS:LECO
NasdaqGS:LECOMachinery

Lincoln Electric Quality Screen Win Puts Valuation And Debt In Focus

Lincoln Electric Holdings (NasdaqGS:LECO) was recently recognized for its financial health and competitive advantages after passing a respected quality investing screen. The screen highlights companies with resilient balance sheets, consistent execution, and durable business models. This recognition singles out Lincoln Electric’s long term positioning in welding, cutting, and joining solutions as especially robust. Lincoln Electric focuses on arc welding equipment, consumables, and...
NYSE:SPXC
NYSE:SPXCMachinery

Is It Too Late To Consider SPX Technologies (SPXC) After A 5-Year 297% Rally?

If you are wondering whether SPX Technologies at around US$217 a share still offers value, you are not alone, and that is exactly what this article aims to unpack. The share price sits at US$217.13, with returns of 1.6% over the past week, 5.7% over the last 30 days, 6.8% year to date, 40.7% over 1 year, 202.2% over 3 years, and 297.1% over 5 years, which naturally raises questions about what is already priced in and what might come next. Recent attention on SPX Technologies has centered on...
NYSE:GPGI
NYSE:GPGITech

Is It Too Late To Consider CompoSecure (CMPO) After Its Recent Share Price Surge

If you are wondering whether CompoSecure's share price still reflects fair value after its recent run, this article will walk through what the current market price might be implying about the business. The stock last closed at US$25.15, with returns of 29.7% over the past 30 days, 34.7% year to date, 97.7% over the past year, and a very large gain over three years that is a little more than 4x. Recent coverage has highlighted CompoSecure's position in secure payment and authentication...